Ignite Creation Date:
2025-12-24 @ 1:50 PM
Ignite Modification Date:
2026-02-19 @ 3:18 PM
Study NCT ID:
NCT03627195
Status:
COMPLETED
Last Update Posted:
2020-05-08
First Post:
2018-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-29
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-07
First Submit QC Date:
None
Study First Post Date:
2018-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-04-15
Results First Submit QC Date:
None
Results First Post Date:
2020-05-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-28
Last Update Post Date:
2020-05-08
Last Update Post Date Type:
ACTUAL